A Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants
Clinical trial NCT05505448 · COMPLETED
Trial details
- NCT number
- NCT05505448
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2023-05-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.